Tapewire

Nasdaq · USD

CDNA

CareDx, Inc.

Export transactions ↓
Tapewire entity
4344
SEC CIK
0001217234
Parsed reports
707

Last 12 months

Inside the activity.

0 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202502
Jan 202603
Feb 202601
Mar 202600
Apr 202601
May 202603
Jun 202606
Jul 202604
Aug 202605
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 21, 2025 Filed Mar 25, 2025 20:35 UTC
Meng JessicaChief Commercial Officer
GrantCommon Stock 61,756 $0.00 $0.00
Disclosure

SEC source: 0002036499-25-000002 · wk-form4_1742934907.xml · nonDerivative · entry 1

Meng Jessica · CIK 0002036499 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,332

F1 · shares: The reported securities are represented by restricted stock units, of which one-third will vest on April 1, 2026 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the restricted stock units will be vested on the third anniversary of April 1, 2026, subject to the Reporting Person's continuous employment on each applicable vesting date.

Read SEC document
March 21, 2025 Filed Mar 25, 2025 20:34 UTC
Kennedy KeithChief Operating Officer
GrantCommon Stock 77,195 $0.00 $0.00
Disclosure

SEC source: 0001543503-25-000002 · wk-form4_1742934827.xml · nonDerivative · entry 1

Kennedy Keith · CIK 0001543503 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,296

F1 · shares: The reported securities are represented by restricted stock units, of which one-third will vest on April 1, 2026 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the restricted stock units will be vested on the third anniversary of April 1, 2026, subject to the Reporting Person's continuous employment on each applicable vesting date.

Read SEC document
March 21, 2025 Filed Mar 25, 2025 20:32 UTC
Jain AbhishekChief Financial Officer
GrantCommon Stock 55,580 $0.00 $0.00
Disclosure

SEC source: 0001931277-25-000006 · wk-form4_1742934765.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337,683

F1 · shares: The reported securities are represented by restricted stock units, of which one-third will vest on April 1, 2026 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the restricted stock units will be vested on the third anniversary of April 1, 2026, subject to the Reporting Person's continuous employment on each applicable vesting date.

Read SEC document
March 21, 2025 Filed Mar 25, 2025 20:30 UTC
Hanna John Walter JRDirector · President & CEO
GrantCommon Stock 200,706 $0.00 $0.00
Disclosure

SEC source: 0001781127-25-000002 · wk-form4_1742934645.xml · nonDerivative · entry 1

Hanna John Walter JR · CIK 0001781127 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 688,510

F1 · shares: The reported securities are represented by restricted stock units, of which one-third will vest on April 1, 2026 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the restricted stock units will be vested on the third anniversary of April 1, 2026, subject to the Reporting Person's continuous employment on each applicable vesting date.

Read SEC document
March 10, 2025 Filed Mar 12, 2025 20:30 UTC SaleCommon Stock 20,000 $18.36 $367,102.00
Disclosure

SEC source: 0000950170-25-037987 · ownership.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,027

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.0650 to $18.7100, inclusive. The Reporting Person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4

Read SEC document
February 05, 2025 Filed Feb 7, 2025 21:30 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 9,989 $23.32 $232,943.48
Disclosure

SEC source: 0001931277-25-000004 · wk-form4_1738963804.xml · nonDerivative · entry 2

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,103

F2 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of performance restricted stock units.

Read SEC document
February 05, 2025 Filed Feb 7, 2025 21:30 UTC
Jain AbhishekChief Financial Officer
GrantCommon Stock 37,800 $0.00 $0.00
Disclosure

SEC source: 0001931277-25-000004 · wk-form4_1738963804.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 292,092

F1 · shares: The reported securities were subject to a performance restricted stock unit award that was initially granted on February 1, 2023 for a two-year performance period over calendar years 2023 and 2024, which performance was assessed and finalized on February 1, 2025. 50.00% of the reported securities vested on February 1, 2025, but were not delivered until February 5, 2025. 50.00% of the reported securities will vest on February 1, 2026, subject to the Reporting Person's continued service with the Issuer.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 21:30 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 3,512 $23.30 $81,829.25
Disclosure

SEC source: 0002019976-25-000002 · wk-form4_1738791038.xml · nonDerivative · entry 2

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,677

F2 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.1000 to $23.7300, inclusive. The Reporting Person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 21:30 UTC
Novack Jeffrey AdamSecretary and General Counsel
Tax withholdingCommon Stock 2,048 $23.32 $47,759.36
Disclosure

SEC source: 0002019976-25-000002 · wk-form4_1738791038.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,189

F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
February 03, 2025 Filed Feb 6, 2025 02:01 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 11,244 $23.32 $262,210.08
Disclosure

SEC source: 0001931277-25-000002 · wk-form4_1738807280.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,292

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
January 06, 2025 Filed Jan 8, 2025 21:32 UTC GrantCommon Stock 856 $0.00 $0.00
Disclosure

SEC source: 0001366412-25-000003 · wk-form4_1736371956.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,928

F1 · shares: Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
December 04, 2024 Filed Dec 6, 2024 21:32 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 1,917 $26.00 $49,842.00
Disclosure

SEC source: 0002019976-24-000015 · wk-form4_1733520724.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,237

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

Read SEC document
November 26, 2024 Filed Dec 4, 2024 01:54 UTC
Maag PeterDirector
Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $12.24 $0.00
Disclosure

SEC source: 0000950170-24-133034 · ownership.xml · derivative · entry 3

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 5,000 shares

Expires 2028-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024.

F2 · derivative.exercise_date: The shares subject to this option vested fully on June 1, 2022.

Read SEC document
November 26, 2024 Filed Dec 4, 2024 01:54 UTC
Maag PeterDirector
SaleCommon Stock 5,000 $25.00 $125,000.00
Disclosure

SEC source: 0000950170-24-133034 · ownership.xml · nonDerivative · entry 2

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 330,024

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024.

Read SEC document
November 26, 2024 Filed Dec 4, 2024 01:54 UTC
Maag PeterDirector
Exercise / conversionCommon Stock 5,000 $12.24 $61,200.00
Disclosure

SEC source: 0000950170-24-133034 · ownership.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 335,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024.

Read SEC document
November 25, 2024 Filed Dec 3, 2024 21:31 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 858 $24.00 $20,592.00
Disclosure

SEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 5

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,154

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

Read SEC document
November 25, 2024 Filed Dec 3, 2024 21:31 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 365 $24.00 $8,760.00
Disclosure

SEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 4

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,012

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

Read SEC document
November 18, 2024 Filed Dec 3, 2024 21:31 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 1,071 $22.00 $23,562.00
Disclosure

SEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 3

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,377

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

Read SEC document
November 18, 2024 Filed Dec 3, 2024 21:31 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 807 $22.00 $17,754.00
Disclosure

SEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 2

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,448

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

Read SEC document
November 18, 2024 Filed Dec 3, 2024 21:31 UTC
Novack Jeffrey AdamSecretary and General Counsel
SaleCommon Stock 3,656 $21.65 $79,160.81
Disclosure

SEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,255

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.34 to $21.94, inclusive. The Reporting Person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
November 06, 2024 Filed Nov 8, 2024 21:35 UTC
Novack Jeffrey AdamSecretary and General Counsel
Tax withholdingCommon Stock 452 $23.21 $10,490.92
Disclosure

SEC source: 0002019976-24-000013 · wk-form4_1731101725.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,911

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:34 UTC
Novack Jeffrey AdamSecretary and General Counsel
Tax withholdingCommon Stock 1,905 $22.64 $43,129.20
Disclosure

SEC source: 0002019976-24-000012 · wk-form4_1730842447.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,363

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:42 UTC Exercise / conversionStock Option (right to buy) · Derivative 2,226 $0.00 Strike: $5.49 $0.00
Disclosure

SEC source: 0000950170-24-121567 · ownership.xml · derivative · entry 4

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,226 shares

Expires 2024-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to this option vested fully on November 8, 2018.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:42 UTC Exercise / conversionStock Option (right to buy) · Derivative 5,255 $0.00 Strike: $5.85 $0.00
Disclosure

SEC source: 0000950170-24-121567 · ownership.xml · derivative · entry 3

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,255 shares

Expires 2025-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to this option vested fully on June 17, 2016.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:42 UTC Exercise / conversionCommon Stock 2,226 $5.49 $12,220.74
Disclosure

SEC source: 0000950170-24-121567 · ownership.xml · nonDerivative · entry 2

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,027

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:42 UTC Exercise / conversionCommon Stock 5,255 $5.85 $30,741.75
Disclosure

SEC source: 0000950170-24-121567 · ownership.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,801

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:31 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 7,371 $22.64 $166,879.44
Disclosure

SEC source: 0001931277-24-000017 · wk-form4_1730842282.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,536

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 20:37 UTC GrantCommon Stock 837 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-113557 · ownership.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,072

F1 · shares: Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:45 UTC
Kennedy KeithChief Operating Officer
GrantEmployee Stock Option (right to buy) · Derivative 100,651 $0.00 Strike: $29.43 $0.00
Disclosure

SEC source: 0001543503-24-000005 · wk-form4_1726519530.xml · derivative · entry 2

Kennedy Keith · CIK 0001543503 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,651

Underlying: Common Stock · 100,651 shares

Expires 2034-09-12

F2 · derivative.exercise_date: 1/4th of the shares subject to this option shall vest on September 12, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter through September 30, 2028.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:45 UTC
Kennedy KeithChief Operating Officer
GrantCommon Stock 70,101 $0.00 $0.00
Disclosure

SEC source: 0001543503-24-000005 · wk-form4_1726519530.xml · nonDerivative · entry 1

Kennedy Keith · CIK 0001543503 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,101

F1 · shares: The reported securities are represented by restricted stock units, which will vest in four equal annual installments on the anniversary of the grant date until fully vested on September 12, 2028.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:42 UTC
Meng JessicaChief Commercial Officer
GrantEmployee Stock Option (right to buy) · Derivative 75,488 $0.00 Strike: $29.43 $0.00
Disclosure

SEC source: 0002036499-24-000003 · wk-form4_1726519368.xml · derivative · entry 2

Meng Jessica · CIK 0002036499 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,488

Underlying: Common Stock · 75,488 shares

Expires 2034-09-12

F2 · derivative.exercise_date: 1/4th of the shares subject to this option shall vest on September 12, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter through September 30, 2028.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:42 UTC
Meng JessicaChief Commercial Officer
GrantCommon Stock 52,576 $0.00 $0.00
Disclosure

SEC source: 0002036499-24-000003 · wk-form4_1726519368.xml · nonDerivative · entry 1

Meng Jessica · CIK 0002036499 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,576

F1 · shares: The reported securities are represented by restricted stock units, which will vest in four equal annual installments on the anniversary of the grant date until fully vested on September 12, 2028.

Read SEC document
September 09, 2024 Filed Sep 11, 2024 20:38 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 2,807 $27.43 $76,996.01
Disclosure

SEC source: 0001931277-24-000015 · wk-form4_1726087097.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,907

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
September 06, 2024 Filed Sep 10, 2024 20:31 UTC
Jain AbhishekChief Financial Officer
Tax withholdingCommon Stock 697 $27.10 $18,888.70
Disclosure

SEC source: 0001931277-24-000013 · wk-form4_1726000309.xml · nonDerivative · entry 1

Jain Abhishek · CIK 0001931277 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,714

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
August 21, 2024 Filed Aug 22, 2024 17:15 UTC Exercise / conversionEmployee Stock Option (right to buy) · Derivative 21,557 $0.00 Strike: $23.48 $0.00
Disclosure

SEC source: 0001617150-24-000012 · wk-form4_1724361333.xml · derivative · entry 6

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,569

Underlying: Common Stock · 21,557 shares

Expires 2032-08-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4th of the shares subject to this option vested on June 16, 2023 and the remaining 3/4th of the shares subject to this option will vest monthly thereafter in 35 equal installments of 2,347 shares and one installment of 281 shares, until fully vested.

Read SEC document
August 21, 2024 Filed Aug 22, 2024 17:15 UTC SaleCommon Stock 21,557 $32.58 $702,327.06
Disclosure

SEC source: 0001617150-24-000012 · wk-form4_1724361333.xml · nonDerivative · entry 4

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,983

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.98, inclusive.

Read SEC document
August 21, 2024 Filed Aug 22, 2024 17:15 UTC Exercise / conversionCommon Stock 21,557 $23.48 $506,158.36
Disclosure

SEC source: 0001617150-24-000012 · wk-form4_1724361333.xml · nonDerivative · entry 3

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 306,540

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 17:15 UTC Exercise / conversionEmployee Stock Option (right to buy) · Derivative 39,466 $0.00 Strike: $23.48 $0.00
Disclosure

SEC source: 0001617150-24-000012 · wk-form4_1724361333.xml · derivative · entry 5

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,126

Underlying: Common Stock · 39,466 shares

Expires 2032-08-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4th of the shares subject to this option vested on June 16, 2023 and the remaining 3/4th of the shares subject to this option will vest monthly thereafter in 35 equal installments of 2,347 shares and one installment of 281 shares, until fully vested.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 17:15 UTC SaleCommon Stock 39,466 $33.17 $1,309,087.22
Disclosure

SEC source: 0001617150-24-000012 · wk-form4_1724361333.xml · nonDerivative · entry 2

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,983

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.75, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 17:15 UTC Exercise / conversionCommon Stock 39,466 $23.48 $926,661.68
Disclosure

SEC source: 0001617150-24-000012 · wk-form4_1724361333.xml · nonDerivative · entry 1

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 324,449

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:43 UTC
Maag PeterDirector
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 26,708 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0000950170-24-099887 · ownership.xml · derivative · entry 5

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,428

Underlying: Common Stock · 26,708 shares

Expires 2033-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option was originally granted on June 16, 2023 and, as of June 16, 2024, was fully vested.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:43 UTC
Maag PeterDirector
SaleCommon Stock 12,818 $32.67 $418,764.06
Disclosure

SEC source: 0000950170-24-099887 · ownership.xml · nonDerivative · entry 4

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,024

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.345 to $33.000, inclusive.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:43 UTC
Maag PeterDirector
SaleCommon Stock 13,890 $33.25 $461,842.50
Disclosure

SEC source: 0000950170-24-099887 · ownership.xml · nonDerivative · entry 3

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342,842

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.75, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:43 UTC
Maag PeterDirector
SaleCommon Stock 8,844 $33.23 $293,886.12
Disclosure

SEC source: 0000950170-24-099887 · ownership.xml · nonDerivative · entry 2

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 356,732

Read SEC document
August 20, 2024 Filed Aug 22, 2024 20:43 UTC
Maag PeterDirector
Exercise / conversionCommon Stock 26,708 $7.96 $212,595.68
Disclosure

SEC source: 0000950170-24-099887 · ownership.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,576

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2024 Filed Aug 21, 2024 16:38 UTC SaleCommon Stock 23,548 $33.52 $789,328.96
Disclosure

SEC source: 0001617150-24-000011 · wk-form4_1724272686.xml · nonDerivative · entry 3

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,983

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.51 to $33.67, inclusive.

Read SEC document
August 19, 2024 Filed Aug 21, 2024 16:38 UTC SaleCommon Stock 2,683 $33.83 $90,765.89
Disclosure

SEC source: 0001617150-24-000011 · wk-form4_1724272686.xml · nonDerivative · entry 2

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,531

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.82 to $33.83, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
August 19, 2024 Filed Aug 21, 2024 16:38 UTC SaleCommon Stock 8,000 $33.53 $268,240.00
Disclosure

SEC source: 0001617150-24-000011 · wk-form4_1724272686.xml · nonDerivative · entry 1

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,214

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:40 UTC
Novack Jeffrey AdamSecretary and General Counsel
Tax withholdingCommon Stock 1,905 $23.58 $44,919.90
Disclosure

SEC source: 0002019976-24-000010 · wk-form4_1722890412.xml · nonDerivative · entry 1

Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,268

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 16:44 UTC Tax withholdingCommon Stock 7,371 $23.58 $173,808.18
Disclosure

SEC source: 0001617150-24-000009 · wk-form4_1722890648.xml · nonDerivative · entry 1

Johnson Alexander L · CIK 0001617150 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,214

F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.